These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35941590)
1. Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test. Zywicki V; Capozza P; Caravelli P; Del Prato S; De Caterina R Cardiovasc Diabetol; 2022 Aug; 21(1):152. PubMed ID: 35941590 [TBL] [Abstract][Full Text] [Related]
2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T; Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481 [TBL] [Abstract][Full Text] [Related]
3. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes. Hage C; Lundman P; Rydén L; Mellbin L Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695 [TBL] [Abstract][Full Text] [Related]
4. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES). Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335 [TBL] [Abstract][Full Text] [Related]
5. Elevated 1-h post-load plasma glucose levels in normal glucose tolerance children with obesity is associated with early carotid atherosclerosis. Kılınç S; Demirbaş T; Atay E; Ceran Ö; Atay Z Obes Res Clin Pract; 2020; 14(2):136-141. PubMed ID: 32061583 [TBL] [Abstract][Full Text] [Related]
6. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S; J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736 [TBL] [Abstract][Full Text] [Related]
7. High incidence of abnormal glucose metabolism in acute coronary syndrome patients at a moderate altitude: A sub-Himalayan study. Mokta J; Kumar S; Ganju N; Mokta K; Panda PK; Gupta S Indian J Endocrinol Metab; 2017; 21(1):142-147. PubMed ID: 28217514 [TBL] [Abstract][Full Text] [Related]
8. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248 [TBL] [Abstract][Full Text] [Related]
9. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening. Adam JM; Tarigan NP Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695 [TBL] [Abstract][Full Text] [Related]
10. One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension. Bergman M; Chetrit A; Roth J; Jagannathan R; Sevick M; Dankner R Diabetes Res Clin Pract; 2016 Oct; 120():221-8. PubMed ID: 27596059 [TBL] [Abstract][Full Text] [Related]
11. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test. Retnakaran R; Zinman B; Connelly PW; Sermer M; Hanley AJ Diabetes Care; 2006 Jan; 29(1):57-62. PubMed ID: 16373896 [TBL] [Abstract][Full Text] [Related]
12. The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation. Tokodai K; Amada N; Haga I; Takayama T; Nakamura A Diabetes Res Clin Pract; 2014 Feb; 103(2):298-303. PubMed ID: 24468096 [TBL] [Abstract][Full Text] [Related]
13. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375 [TBL] [Abstract][Full Text] [Related]
14. Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects. Robles-Osorio L; Aguilar-Salinas CA; Mehta R; Gómez-Pérez FJ; Rull JA Endocr Pract; 2007 Oct; 13(6):583-9. PubMed ID: 17954413 [TBL] [Abstract][Full Text] [Related]
15. Can admission and fasting glucose reliably identify undiagnosed diabetes in patients with acute coronary syndrome? Okosieme OE; Peter R; Usman M; Bolusani H; Suruliram P; George L; Evans LM Diabetes Care; 2008 Oct; 31(10):1955-9. PubMed ID: 18591399 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608 [TBL] [Abstract][Full Text] [Related]
17. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study. George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia. Kuhl J; Jörneskog G; Wemminger M; Bengtsson M; Lundman P; Kalani M Cardiovasc Diabetol; 2015 Sep; 14():120. PubMed ID: 26382578 [TBL] [Abstract][Full Text] [Related]
19. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Motala AA; Omar MA; Gouws E Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444 [TBL] [Abstract][Full Text] [Related]
20. Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study. Hage C; Brismar K; Efendic S; Lundman P; Rydén L; Mellbin L J Intern Med; 2013 Apr; 273(4):410-21. PubMed ID: 23331339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]